AbbVie Inc. reports $17.4 billion revenue for quarter ended September 30, 2026, up 10.3%
AbbVie Inc. reported revenue of $17.4 billion for the quarter ended September 30, 2026, an increase of 10.3% from the same quarter a year earlier ($15.78 billion).
For the same period it posted net income of $4.22 billion, up 2167.7%, or $2.37 per diluted share (0.10 a year earlier).
That is a net margin of 24.2%.
On Sanad's AAOIFI Standard 21 screen, AbbVie Inc. is currently compliant: interest-bearing debt is 15.6% of market capitalisation (limit 30%), and impure income is 0.4% of revenue (limit 5%).
Is AbbVie Inc. halal?
See the full AAOIFI screening of AbbVie Inc.
See the full AAOIFI screening of AbbVie Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on November 3, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.